243 related articles for article (PubMed ID: 22910806)
1. Exposure to potentially dangerous drug-drug interactions involving antipsychotics.
Guo JJ; Wu J; Kelton CM; Jing Y; Fan H; Keck PE; Patel NC
Psychiatr Serv; 2012 Nov; 63(11):1080-8. PubMed ID: 22910806
[TBL] [Abstract][Full Text] [Related]
2. Variation in long-term antipsychotic polypharmacy and high-dose prescribing across physicians and hospitals.
Latimer EA; Naidu A; Moodie EE; Clark RE; Malla AK; Tamblyn R; Wynant W
Psychiatr Serv; 2014 Oct; 65(10):1210-7. PubMed ID: 24981557
[TBL] [Abstract][Full Text] [Related]
3. Prescription practices in the treatment of agitation in newly hospitalized Chinese schizophrenia patients: data from a non-interventional naturalistic study.
Zhang SZ; Mu YG; Liu Q; Shi Y; Guo LH; Li LZ; Yang FD; Wang Y; Li T; Mei QY; He HB; Chen ZY; Su ZH; Liu TB; Xie SP; Tan QR; Zhang JB; Zhang CP; Sang H; Mi WF; Zhang HY
BMC Psychiatry; 2019 Jul; 19(1):216. PubMed ID: 31291931
[TBL] [Abstract][Full Text] [Related]
4. Prevalence, trends, and factors associated with antipsychotic polypharmacy among Medicaid-eligible schizophrenia patients, 1998-2000.
Ganguly R; Kotzan JA; Miller LS; Kennedy K; Martin BC
J Clin Psychiatry; 2004 Oct; 65(10):1377-88. PubMed ID: 15491242
[TBL] [Abstract][Full Text] [Related]
5. From conventional to atypical antipsychotics and back: dynamic processes in the diffusion of new medications.
Leslie DL; Rosenheck RA
Am J Psychiatry; 2002 Sep; 159(9):1534-40. PubMed ID: 12202274
[TBL] [Abstract][Full Text] [Related]
6. A Non-Interventional Naturalistic Study of the Prescription Patterns of Antipsychotics in Patients with Schizophrenia from the Spanish Province of Tarragona.
Gaviria AM; Franco JG; Aguado V; Rico G; Labad J; de Pablo J; Vilella E
PLoS One; 2015; 10(10):e0139403. PubMed ID: 26427051
[TBL] [Abstract][Full Text] [Related]
7. Diagnoses associated with use of atypical antipsychotics in a commercial health plan: a claims database analysis.
Citrome L; Kalsekar I; Guo Z; Laubmeier K; Hebden T
Clin Ther; 2013 Dec; 35(12):1867-75. PubMed ID: 24119767
[TBL] [Abstract][Full Text] [Related]
8. Geographic and clinical variation in clozapine use in the United States.
Stroup TS; Gerhard T; Crystal S; Huang C; Olfson M
Psychiatr Serv; 2014 Feb; 65(2):186-92. PubMed ID: 24233347
[TBL] [Abstract][Full Text] [Related]
9. Prescribing of antipsychotics in UK primary care: a cohort study.
Marston L; Nazareth I; Petersen I; Walters K; Osborn DP
BMJ Open; 2014 Dec; 4(12):e006135. PubMed ID: 25524544
[TBL] [Abstract][Full Text] [Related]
10. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ
Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of medicaid beneficiaries with schizophrenia receiving clozapine only or antipsychotic combinations.
Velligan DI; Carroll C; Lage MJ; Fairman K
Psychiatr Serv; 2015 Feb; 66(2):127-33. PubMed ID: 25321616
[TBL] [Abstract][Full Text] [Related]
12. Hyperlipidemia following treatment with antipsychotic medications.
Olfson M; Marcus SC; Corey-Lisle P; Tuomari AV; Hines P; L'Italien GJ
Am J Psychiatry; 2006 Oct; 163(10):1821-5. PubMed ID: 17012695
[TBL] [Abstract][Full Text] [Related]
13. Drug prescription patterns in schizophrenia outpatients: analysis of data from a German health insurance fund.
Weinbrenner S; Assion HJ; Stargardt T; Busse R; Juckel G; Gericke CA
Pharmacopsychiatry; 2009 Mar; 42(2):66-71. PubMed ID: 19308881
[TBL] [Abstract][Full Text] [Related]
14. [Antipsychotic prescription patterns in patients affiliated to the Social Security Health System in Colombia].
Machado-Alba JE; Morales-Plaza CD
Biomedica; 2013; 33(3):418-28. PubMed ID: 24652178
[TBL] [Abstract][Full Text] [Related]
15. Risperidone long-acting therapy prescribing patterns and their impact on early discontinuation of treatment in a large Medicaid population.
Boaz TL; Constantine RJ; Robst J; Becker MA; Howe AM
J Clin Psychiatry; 2011 Aug; 72(8):1079-85. PubMed ID: 21034690
[TBL] [Abstract][Full Text] [Related]
16. The prescription patterns of second-generation antipsychotics in schizophrenia outpatient setting.
Julaeha J; Athiyah U; Hermansyah A
J Basic Clin Physiol Pharmacol; 2019 Dec; 30(6):. PubMed ID: 31837257
[TBL] [Abstract][Full Text] [Related]
17. [Pharmaco-epidemiological study on antipsychotic drug prescription in French Psychiatry: Patient characteristics, antipsychotic treatment, and care management for schizophrenia].
Brunot A; Lachaux B; Sontag H; Casadebaig F; Philippe A; Rouillon F; Cléry-Melin P; Hergueta T; Llorca PM; Moreaudefarges T; Guillon P; Lebrun T
Encephale; 2002; 28(2):129-38. PubMed ID: 11972139
[TBL] [Abstract][Full Text] [Related]
18. Medical decision making in antipsychotic drug choice for schizophrenia.
Hamann J; Langer B; Leucht S; Busch R; Kissling W
Am J Psychiatry; 2004 Jul; 161(7):1301-4. PubMed ID: 15229068
[TBL] [Abstract][Full Text] [Related]
19. Impact of patients' preexisting metabolic risk factors on the choice of antipsychotics by office-based physicians.
Li C; Mittal D; Owen RR
Psychiatr Serv; 2011 Dec; 62(12):1477-84. PubMed ID: 22193796
[TBL] [Abstract][Full Text] [Related]
20. Antipsychotic use in the treatment of outpatients with schizophrenia in the VA from fiscal years 1999 to 2006.
Sernyak MJ; Rosenheck RA
Psychiatr Serv; 2008 May; 59(5):567-9. PubMed ID: 18451019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
